ACO Name and Location:

Commonwealth Primary Care ACO
5005 S. Ash Ave Ste A-1
Tempe, Arizona 85282

ACO Primary Contact:

Primary Contact Name                  Lance Donkerbrook, CEO
Primary Contact Phone Number    480-296-1276
Primary Contact Email Address      ldonkerbrook@commonwealthaco.com

Organizational Information:

ACO Participants:

ACO ParticipantsACO Participant in Joint Venture (Enter Y or N)
ANA M SIERRA DE ARAGON MDN
Alex J. Onofrei MD, PCN
BOWSER' GARDEN LLCN
Cholla Medical Group, Inc.N
DILIP C DHADVHAI MD PCN
Dr. Kevin Chan, PCN
East Flagstaff Family Medicine, LTDN
Generations Family Practice, PLLCN
HealthFirst Primary CareN
James Nichols Md, Ltd.N
Jigna Patel MD PLLCN
Leon A Driss PCN
MD24 AZ DOCTORS INCN
Mark D. Goldberg, MD PCN
PAGE FAMILY PRACTICE PLLCN
PREMIER MEDICAL GROUP LLCN
Petar N Novakovic MD PCN
Primary Care Associates, PLLCN
Quality of Life Medical Center, LLCN
Ravi Gupta MD, PLLCN
Robert J Bloomberg MD PCN
RAJIV PARIKH MD PCN
Ryan Internal Medicine, P.C.N
SELLERSSPORTSMED LLCN
The Wellness Medical Clinic PcN
Thomas C. Fiel DO PCN
Timothy C. Bryan, Md, PlcN
West Park Medical CorpN

ACO Governing Body:

Member     
Last NameFirst NameTitle/PositionMember's Voting PowerMembership TypeACO Participant TIN Legal Business Name/DBA, if Applicable
DonkerbrookLanceCEO1 VoteVoting Member
VothRJMedicare Beneficiary Representative, Board Chair1 VoteVoting Member
AragonAnaACO Participant Representative1 VoteVoting MemberANA M SIERRA DE ARAGON MD
BloombergRobertACO Participant Representative1 VoteVoting MemberRobert J Bloomberg MD PC
GuptaRaviACO Participant Representative1 VoteVoting MemberRavi Gupta MD, PLLC
McGettiganJohnACO Participant Representative1 VoteVoting MemberQuality of Life Medical Center, LLC
NicholsJamesACO Participant Representative1 VoteVoting MemberJames Nichols, Md Ltc
NovakovicPetarACO Participant Representative1 VoteVoting MemberPetar Novakovic MD PC
ParikhRajivACO Participant Representative1 VoteVoting MemberRAJIV PARIKH MD PC

Key ACO clinical and administrative leadership:

  • Lance Donkerbrook                ACO Executive
  • James Nichols, MD                 Medical Director
  • Robert Bloomberg, MD           Compliance Officer
  • Jason Jones, DO                      Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee NameCommittee Leader Name and Position
Physician Engagement and Operations SubcommitteeJames Nichols, MD - Chair
Clinical and Quality Improvement CommitteeJason Jones, DO - Chair
Compliance and Ethics CommitteeRobert Bloomberg, MD - Chair

Types of ACO participants or combinations of participants that formed the ACO:

    • Network of individual practices of ACO professionals

Shared Savings and Losses:

Amount of Shared Savings/Losses

  • Third Agreement Period
    • Performance Year 2020: $0
    • Performance Year 2019: $1,042,086
  • Second Agreement Period
    • Performance Year 2019: $1,042,086
    • Performance Year 2018: $2,442,372
    • Performance Year 2017: $0
    • Performance Year 2016: $0
  • First Agreement Period
    • Performance Year 2015: $7,404,173
    • Performance Year 2014: $0
    • Performance Year 2013: $0

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Shared Savings Distribution

  • Third Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: 50%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 30%
  • Second Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: 50%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 30%
    • Performance Year 2018
      • Proportion invested in infrastructure: 60%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 20%
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2015
      • Proportion invested in infrastructure: 33%
      • Proportion invested in redesigned care processes/resources: 7%
      • Proportion of distribution to ACO participants: 40%
      • Proportion of distribution to Contractual and Other Obligations: 20%
    • Performance Year 2014:
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2013:
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.

Quality Performance Results

2020 Quality Performance Results:

Measure NumberMeasure Name2020 Reporting Period
ACO Performance RateMean Performance Rate (SSP-ACOs)
ACO-43Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator(PQI #91))0.720.92
ACO-13Falls: Screening for Future Fall Risk85.3683.21
ACO-14Preventive Care and Screening: Influenza Immunization83.5875.10
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention95.8379.90
ACO-18Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan83.5369.15
ACO-19Colorectal Cancer Screening86.3771.50
ACO-20Breast Cancer Screening82.2672.92
ACO-42Statin Therapy for the Prevention and Treatment of Cardiovascular Disease91.2482.99
ACO-27Diabetes: Hemoglobin A1c Poor Control (>9%) 9.6813.72
ACO-28Controlling High Blood Pressure88.2571.73

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.
  • Waiver for Payment for Telehealth Services:
    • Our ACO clinicians provide tele-health services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.

Fraud and Abuse Waivers

  • ACO Pre-Participation Waiver:

The following information describes each arrangement for which our ACO seeks protection under the ACO Pre-Participation Waiver, including any material amendment or modification to a disclosed arrangement.

[For each arrangement, provide the following information:

  • Parties to the arrangement: N/A
  • Date of arrangement: N/A
  • Items, services, goods, or facility provided: N/A
  • Date and nature of any amendments to the arrangement, if applicable: N/A
  • ACO Participation Waiver:

The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.

[For each arrangement, provide the following information:

  • Parties to the arrangement: N/A
  • Date of arrangement: N/A
  • Items, services, goods, or facility provided: N/A
  • Date and nature of any amendments to the arrangement, if applicable: N/A